Showing results (111-120 of 119) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 119 results.
Neurology|February 3, 2017
High-dose immunosuppressive therapy and autologous HCT for relapsing-remitting MSRichard A Nash, George J Hutton, Michael K Racke, et al.
Therapeutic Advances in Neurological Disorders|December 25, 2010
A randomized, blinded, parallel-group, pilot trial of mycophenolate mofetil (CellCept) compared with interferon beta-1a (Avonex) in patients with relapsing-remitting multiple sclerosisElliot M Frohman, Gary Cutter, Gina Remington, et al.
Journal of Biomedical Science|February 19, 2025
K27-linked RORγt ubiquitination by Nedd4 potentiates Th17-mediated autoimmunityQiuming Zeng, Hui Guo, Na Tang, et al.
Small Methods|June 14, 2023
Microfluidic Immuno-Serolomic Assay Reveals Systems Level Association with COVID-19 Pathology and Vaccine ProtectionDongjoo Kim, Giulia Biancon, Zhiliang Bai, et al.
Biorxiv : the Preprint Server for Biology|September 12, 2022
Microfluidic immuno-serology assay revealed a limited diversity of protection against COVID-19 in patients with altered immunityDongjoo Kim, Giulia Biancon, Zhiliang Bai, et al.
JAMA Neurology|December 30, 2014
High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for relapsing-remitting multiple sclerosis (HALT-MS): a 3-year interim reportRichard A Nash, George J Hutton, Michael K Racke, et al.
Brain : a Journal of Neurology|February 11, 2010
Pharmacological prion protein silencing accelerates central nervous system autoimmune disease via T cell receptor signallingWei Hu, Stefan Nessler, Bernhard Hemmer, et al.
JCI Insight|August 22, 2023
Prior cycles of anti-CD20 antibodies affect antibody responses after repeated SARS-CoV-2 mRNA vaccinationHiromitsu Asashima, Dongjoo Kim, Kaicheng Wang, et al.
The Lancet. Neurology|December 2, 2015
Estriol combined with glatiramer acetate for women with relapsing-remitting multiple sclerosis: a randomised, placebo-controlled, phase 2 trialRhonda R Voskuhl, HeJing Wang, T C Jackson Wu, et al.
Pageof 12